Riskpilot← Back to searchSign inGet full accessArtegina AB
ABActiveOrg 5568805393Ridhusvägen 13Research and experimental development on natural sciences and engineering · NACE 7210Est. 20120 employees
Revenue 2025
SEK 18K
-71% vs 2024
EBITDA margin
-186.0%
-22572% vs 2024
Equity ratio
-403.6%
Financial strength
Net profit 2025
SEK -33K
-30239% vs 2024
| Revenue | SEK 18K | -71% |
| EBITDA | SEK -33K | -22572% |
| Net profit | SEK -33K | -30239% |
| Total assets | SEK 9K | -54% |
| Equity | SEK -35K | -1737% |
| Employees | 0 | — |
Legal name
Artegina AB
Org number
5568805393
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
12 januari 2012
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva produktion av litterära verk och förlagsverksamhet, utbildnings- och konsultverksamhet inom medicin, äga och förvalta rättigheter och patent för medicinska och medicintekniska uppfinningar, samt därmed förenlig verksamhet.
Address
Ridhusvägen 13
Email
artur.fedorowski@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 57 | 74 | 97 | 61 | 18 |
| Staff expenses | — | — | — | — | −12 |
| EBITDA | −7 | −5 | 3 | −0 | −33 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −7 | −5 | 3 | −0 | −33 |
| Net financials | — | −0 | −0 | 0 | 0 |
| Profit before tax | −7 | −5 | 3 | −0 | −33 |
| Tax | −0 | — | — | — | — |
| Net profit | −7 | −5 | 3 | −0 | −33 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 34 | 24 | 36 | 19 | 9 |
| Equity | 0 | −5 | −2 | −2 | −35 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 34 | 29 | 38 | 21 | 44 |
| Total debt | 34 | 29 | 38 | 21 | 44 |
EBITDA margin
-186.0%
This company
15.8%
Market median
-1277% vs market
20212025
Equity ratio
-403.6%
This company
38.2%
Market median
-1157% vs market
20212025
Return on equity
-3307000.0%
This company
18.4%
Market median
-17972926% vs market
20212025
Net profit margin
-185.8%
This company
8.1%
Market median
-2394% vs market
20212025
Asset turnover
2.05×
This company
1.12×
Market median
+83% vs market
20212025
Debt / equity
1.25×
This company
0.62×
Market median
-102% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
UM | Audit | 2022 |
AK Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Artegina AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Martin Ingvar Gustafsson | Audit | 0 companies |
| Agnieszka Katarzyna Fedorowska | Chief Executive Officer | 0 companies |
| Artur Piotr Fedorowski | Deputy Board Member | 0 companies |